ANGLE (LON:AGL) Earns Buy Rating from Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of ANGLE (LON:AGL) in a report released on Wednesday morning, Marketbeat Ratings reports. They currently have a GBX 70 ($0.86) target price on the stock.

ANGLE Stock Up 0.8 %

Shares of ANGLE stock opened at GBX 15.62 ($0.19) on Wednesday. The firm’s 50 day moving average price is GBX 14.47 and its 200-day moving average price is GBX 14.04. The company has a quick ratio of 6.18, a current ratio of 7.51 and a debt-to-equity ratio of 14.26. ANGLE has a 52-week low of GBX 9.07 ($0.11) and a 52-week high of GBX 37.40 ($0.46). The company has a market cap of £40.70 million, a P/E ratio of -173.54 and a beta of 0.20.

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.